High-dose dazucorilant showed significant survival benefit in a Phase 2 ALS trial. It reduced mortality risk by up to 87% over two years for ALS patients. A pivotal Phase 3 trial for this ALS therapy ...
May is ALS Awareness Month, and in the U.S. and around the world, organizations are educating, sponsoring events, and encouraging the community to join them in taking action, providing financial ...
ALS death rates in Finland nearly doubled between 1987 and 2022, especially in older adults, a study found. Researchers noted that this trend has not been observed in other countries, such as the U.S.
As Todd’s ALS progressed, he wasn’t able to get out of the house much, and Comet became his office companion for much of the ...
In the early, scary months after my late husband, Jeff, was diagnosed with ALS in the fall of 2018, I started to realize that ...
The MDA Wings Over Wall Street Gala raises funds for ALS research. The event unites financial and medical communities to find a cure. More than $13 million has been raised since 2000, driving research ...
Masitinib treatment for ALS led to 42% of patients in a clinical trial surviving five years, nearly double historical rates, ...
Long-term exposure to air pollution is not associated with an altered, or increased, risk of amyotrophic lateral sclerosis ...
In the early years after my ALS diagnosis, those braces represented one more massive change in my life that I had to learn to ...
ALS patients often experience weight loss, which is linked to poorer survival. Maintaining body weight after starting tube feeding is associated with longer survival in ALS. Weight stability after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results